Hypera to divest Sanofi products to Eurofarma

19 November 2021 - Deborah Wilkes

Premium

Brazil’s Hypera Pharma has agreed to sell some of the Latin American products it is acquiring from Sanofi to Eurofarma Laboratorios for USD51.6 million.

Click tags below for more information on topics:

Hypera Pharma Eurofarma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: